Goodbody Health Inc. (AQSE: GDBY) has announced that further to the Company’s announcement on 10 January 2022, announcing the change of the Company’s name to Goodbody Health Inc., the Company’s ISIN and SEDOL will be changed to CA3821591011 and BMH29Z0, both with effect from 8 a.m. on 1 February 2022. The Company’s existing ticker GDBY remains unchanged.
As a result of this change it has been necessary to make an application to AQSE for readmission (“Readmission”) of the Company’s existing common shares under the new ISIN and SEDOL. It is expected that Readmission will become effective as at 8.00 a.m. on 1 February 2022.
Following Readmission, the total issued share capital of the Company will remain unchanged at 364,962,152 common shares. There are no common shares held in treasury. Therefore, following Readmission, this figure of 364,962,152 should be used by shareholders as the denominator for the calculation by which they determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules.
